378 related articles for article (PubMed ID: 19492488)
21. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
[TBL] [Abstract][Full Text] [Related]
22. [New antidepressive agents during pregnancy and lactation. Drug concentration should be monitored and the lowest possible dose administered].
Spigset O; Hägg S
Lakartidningen; 2004 Mar; 101(13):1176-81. PubMed ID: 15101242
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
Huybrechts KF; Bateman BT; Palmsten K; Desai RJ; Patorno E; Gopalakrishnan C; Levin R; Mogun H; Hernandez-Diaz S
JAMA; 2015 Jun; 313(21):2142-51. PubMed ID: 26034955
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
[TBL] [Abstract][Full Text] [Related]
25. [Antidepressants-SSRIs in pregnancy and risk of major malformations: treat or not to treat].
Bellantuono C; Santone G
Recenti Prog Med; 2014 Jun; 105(6):254-61. PubMed ID: 25002286
[TBL] [Abstract][Full Text] [Related]
26. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health.
Warburton W; Hertzman C; Oberlander TF
Acta Psychiatr Scand; 2010 Jun; 121(6):471-9. PubMed ID: 19878137
[TBL] [Abstract][Full Text] [Related]
27. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.
Nordeng H; Spigset O
Drug Saf; 2005; 28(7):565-81. PubMed ID: 15963005
[TBL] [Abstract][Full Text] [Related]
28. Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Andrade C
J Clin Psychiatry; 2012 May; 73(5):e601-5. PubMed ID: 22697207
[No Abstract] [Full Text] [Related]
29. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387
[TBL] [Abstract][Full Text] [Related]
30. Does fetal exposure to SSRIs or maternal depression impact infant growth?
Wisner KL; Bogen DL; Sit D; McShea M; Hughes C; Rizzo D; Confer A; Luther J; Eng H; Wisniewski SW
Am J Psychiatry; 2013 May; 170(5):485-93. PubMed ID: 23511234
[TBL] [Abstract][Full Text] [Related]
31. Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns.
Bałkowiec-Iskra E; Mirowska-Guzel DM; Wielgoś M
Ginekol Pol; 2017; 88(1):36-42. PubMed ID: 28157249
[TBL] [Abstract][Full Text] [Related]
32. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
33. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
[TBL] [Abstract][Full Text] [Related]
34. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
Cantor Sackett J; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
[TBL] [Abstract][Full Text] [Related]
35. [Medical treatment of depression during pregnancy and breastfeeding].
Nielsen RE; Stage KB; Christensen PM; Mortensen S; Andersen LL; Damkier P
Ugeskr Laeger; 2007 Apr; 169(16):1442-4. PubMed ID: 17484841
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
37. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].
Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML
Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198
[TBL] [Abstract][Full Text] [Related]
38. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
de Moor RA; Mourad L; ter Haar J; Egberts AC
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
[TBL] [Abstract][Full Text] [Related]
39. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
[TBL] [Abstract][Full Text] [Related]
40. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
